ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 163 filers reported holding ZAI LAB LTD in Q4 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,104,622 | -0.3% | 539,063 | +13.7% | 0.02% | -8.3% |
Q2 2023 | $13,143,770 | +19.5% | 473,991 | +43.3% | 0.02% | +20.0% |
Q1 2023 | $10,998,151 | +14.1% | 330,672 | +5.3% | 0.02% | +5.3% |
Q4 2022 | $9,639,340 | +29.0% | 313,985 | +43.7% | 0.02% | +26.7% |
Q3 2022 | $7,472,000 | -19.2% | 218,485 | -18.0% | 0.02% | +66.7% |
Q2 2022 | $9,245,000 | -21.3% | 266,588 | -0.2% | 0.01% | 0.0% |
Q1 2022 | $11,747,000 | -36.6% | 267,098 | -9.4% | 0.01% | -30.8% |
Q4 2021 | $18,536,000 | -53.8% | 294,932 | -22.5% | 0.01% | -58.1% |
Q3 2021 | $40,102,000 | -42.2% | 380,508 | -2.9% | 0.03% | -47.5% |
Q2 2021 | $69,330,000 | +151.7% | 391,714 | +89.7% | 0.06% | +118.5% |
Q1 2021 | $27,548,000 | +134.4% | 206,462 | +137.7% | 0.03% | +125.0% |
Q4 2020 | $11,755,000 | +200.3% | 86,856 | +84.5% | 0.01% | +140.0% |
Q3 2020 | $3,915,000 | -46.4% | 47,075 | -47.1% | 0.01% | -37.5% |
Q2 2020 | $7,307,000 | -25.4% | 88,965 | -53.2% | 0.01% | -38.5% |
Q1 2020 | $9,792,000 | +8.0% | 190,205 | -12.8% | 0.01% | +62.5% |
Q4 2019 | $9,067,000 | +120.8% | 218,000 | +71.8% | 0.01% | +100.0% |
Q3 2019 | $4,106,000 | +7.0% | 126,925 | +15.3% | 0.00% | 0.0% |
Q2 2019 | $3,839,000 | – | 110,105 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BRILLIANCE ASSET MANAGEMENT LTD | 1,631,887 | $71,770,000 | 28.24% |
Zeal Asset Management Ltd | 351,829 | $15,234,000 | 19.86% |
Tree Line Advisors (Hong Kong) Ltd. | 460,000 | $20,231,000 | 11.97% |
INDUS CAPITAL PARTNERS, LLC | 291,026 | $12,799,000 | 5.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 78,958 | $16,958,000 | 3.82% |
HSG Holding Ltd | 694,634 | $30,550,000 | 3.81% |
EcoR1 Capital, LLC | 2,223,212 | $97,777,000 | 3.06% |
Segantii Capital Management Ltd | 2,252,274 | $99,055,000 | 2.86% |
Privium Fund Management B.V. | 226,752 | $9,973,000 | 2.20% |
Genesis Investment Management, LLP | 820,352 | $36,079,000 | 2.12% |